Ropes & Gray represented Zai Lab Limited in the offering, while Simpson Thacher & Bartlett represented the underwriters. Zai Lab Limited (“Zai Lab” or the “Company”)...
You must be a Standard 1 Year member to access this content.
Maples and Calder acted as British Virgin Islands counsel to Biohaven Ltd. in the offering, and Sullivan & Cromwell acted as New York counsel and Ropes...
You must be a Standard 1 Year member to access this content.
Maples and Calder acted as British Virgin Island counsel to Biohaven Ltd., and Sullivan & Cromwell acted as US counsel, while Ropes & Gray represented the...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Blackstone Life Sciences in the transaction. Blackstone Life Sciences (NYSE:BX) (“Blackstone”) announced a collaboration with Moderna, Inc. (NASDAQ: MRNA, “Moderna”) through a development and...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented LianBio on the deal. LianBio (Nasdaq: LIAN) announced it has entered into an agreement with Bristol Myers Squibb (NYSE:BMY)(BMS), whereby BMS has obtained...
You must be a Standard 1 Year member to access this content.
Ropes & Gray and Kirkland & Ellis acted as legal advisors to Radius. Cravath, Swaine & Moore acted as legal advisor to DRI Healthcare. Radius Pharmaceuticals,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray acted as legal advisor to TransMedics, and Cooley acted as legal advisor to Bridge to Life. TransMedics Group, Inc. (Nasdaq: TMDX) announced that is...
You must be a Standard 1 Year member to access this content.
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
You must be a Standard 1 Year member to access this content.
WilmerHale advised PTC Therapeutics, while Ropes & Gray advised Blackstone on the deal. Blackstone announced a strategic financing collaboration for up to $1 billion in funding...
You must be a Standard 1 Year member to access this content.
Freshfields advised Zymergen Inc. (Nasdaq: ZY) on the deal, while Ropes & Gray advised Ginkgo Bioworks. Zymergen Inc. (Nasdaq: ZY), a biotechnology company that uses a...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented ConvaTec Group in the transaction. ConvaTec Group, a global medical solutions company, executed its acquisition of medical device company, Triad Life Sciences. ...
You must be a Standard 1 Year member to access this content.
Ropes & Gray, NautaDutilh and Bernitsas Law advised Partners Group on the deal, while Kirkland & Ellis and De Brauw advised BC Partners. Partners Group, the...
You must be a Standard 1 Year member to access this content.
